Top Software Companies in Hyderabad (353)

Strong Revenue Growth: Revenue is rising, with 2025 reaching $89.5B (highest since 2018) and Q2 2026 at $24.6B as deliveries increased versus last year. The multi‑quarter trend indicates business scale is recovering.

Healthy Cash Flow: Cash generation is improving, highlighted by Q2 2026 positive operating cash flow and $0.6B in free cash flow. This shift reflects higher deliveries and working‑capital tailwinds.

Resilient & Sustainable Growth: Backlog has reached a record ~$715B, including over 6,200 commercial airplanes, supporting multi‑year production. This depth of contracted demand underpins revenue visibility.

Customer Loyalty & Retention: Dollar Retention Rate reached 105% in Q1 FY2027, up from 91% a year earlier, signaling stronger expansion within existing accounts. New customer agreements on the Percipio platform also grew 67% quarter over quarter, reinforcing account health.

Innovation-Driven Growth: AI-driven learning usage expanded sharply (e.g., AI learners up 74%, total AI learning hours up 158%, and AI skill benchmark completions up 994%), indicating product innovation is resonating. Adoption of the next-generation, AI-native Percipio platform is accelerating as well.

Cost & Operational Efficiency: Adjusted EBITDA margin improved to 28% in Q1 FY2027 and free cash flow strengthened in recent quarters. Net loss narrowed 37% year over year, pointing to tighter operating discipline even on a smaller revenue base.

Investor Backing & Capital Strength: A $90M Series C in May 2025—corroborated by trade press—was secured to expand the AI-driven platform and scale operations. Additional equity raised in 2024 and total capital around $200M signal strong investor support for growth.

Product Line Growth: In September 2025 the company launched a Payment Integrity suite and acquired ZignaAI, extending beyond utilization management into claims/payment accuracy. Subsequent 2026 updates expanded the platform into appeals, care management, claims operations, and quality.

Market Expansion: Payer materials indicate Cohere Health reviews Humana prior authorization requests nationwide, with HealthPartners documents in 2025–2026 showing adoption beyond Humana. Company-reported operating scale (600k+ providers, millions of requests) and added plan wins through 2026 suggest a broader payer footprint.

Strong Revenue Growth: Revenue is accelerating with multiple raised full‑year outlooks and consecutive quarters of rapid top‑line increases. The business also highlights a long “beat and raise” cadence into 2026.

Profitability: GAAP net income turned positive in 2026 alongside expanding adjusted EBITDA. Management continues to guide to improved margins through the year.

Healthy Cash Flow: Free cash flow is rising and full‑year cash generation guidance was increased. Disclosures point to stronger operating cash flow through the first half of 2026.

Strong Revenue Growth: Net revenue continues to rise year over year in the latest full-year and quarterly updates, and management reiterates guidance for continued growth within its target range. This trajectory aligns with broad-based gains in customers, volumes, and account usage.

Profitability: Income before tax remains strong, and margin guidance is maintained alongside ongoing expansion. This points to profitable growth rather than growth at any cost.

Diversified Revenue Streams: A significant share of net revenue now comes from non‑transfer activities such as interest on customer balances, cards, and other account features. This mix reduces reliance on core cross‑border fees as usage of the account and platform deepens.

Strong Revenue Growth: Revenue and ARR are described as rising from roughly $250M in 2023 to about $400M in 2024 and $600M+ by late 2025, with some estimates extending higher into 2026. These sequential milestones point to continued monetization alongside user growth.

Market Expansion: The paying‑customer mix reportedly shifted from about 90% individuals/10% companies to roughly 50/50 by late 2023, and the company states it passed 100M users in 2024. This indicates deeper traction with business buyers and broader reach across segments and geographies.

Healthy Cash Flow: The company was described as cash‑flow positive by December 2025. This suggests operations are helping fund growth without reliance on new primary capital.

Strong Revenue Growth: Revenue is reported to have grown 26% in FY2024, alongside roughly 30% ARR growth in 2023 after surpassing the $100M milestone in 2022. This indicates sustained top-line expansion across consecutive years.

Profitability: The company reports remaining profitable and cash‑flow positive while growing in FY2024. This suggests operational discipline alongside expansion.

Investor Backing & Capital Strength: A July 2024 majority investment led by Vista Equity Partners valued the company at about $1.2B, with participation from TCV and KKR. This financing signals external confidence and provides resources for further expansion.

Strong Revenue Growth: Revenue is rising briskly, with the latest quarter up year over year and full‑year FY2026 guidance raised for both revenue and ARR. Prior billings and deferred revenue growth indicate healthy demand heading into FY2026.

Strong Market Position & Advantage: Independent analyst evaluations place the company as a leader in SSE/SASE and note frequent inclusion on enterprise shortlists. A broad global footprint and regulatory certifications bolster competitiveness in regulated and international markets.

Product Line Growth: Expansion in newer offerings—such as Data Security, AI‑focused modules, and Zero Trust Branch—shows meaningful traction. Metered, non‑seat‑based solutions accounted for a sizable share of new ACV, suggesting broader monetization beyond core seats.

Strong Revenue Growth: Revenue growth is accelerating with Q2 2026 up ~29% year over year and full-year 2026 guidance raised to about 30–31% growth. Management also points to a 35%+ exit rate in Q4 2026 and stronger momentum into 2027.

Innovation-Driven Growth: Recent AI‑Native Cloud launches (15+ new offerings across infrastructure, inference, data, and agents) are credited with fueling demand. AI customer ARR rose sharply in 2026, and record incremental ARR underscores product‑led momentum.

Customer Loyalty & Retention: Net Dollar Retention improved to roughly 101% in late 2025 and 102% in Q2 2026, indicating expanding spend among existing customers. Growing multi‑year commitments, with RPO nearing $900M, add visibility to that expansion.

Strong Revenue Growth: Total revenue increased to $255.9M in 2025 with software up and drug‑discovery more than doubling, while operating expenses declined year over year. Early 2026 also showed momentum, with first‑half revenue modestly higher and Q2 posting year‑over‑year growth.

Strategic Partnerships: New and expanded agreements—such as Bristol Myers Squibb deploying Bunsen and a July 2026 discovery collaboration with Simcere—broaden platform use and collaboration optionality. The Lilly/Ajax transaction also validated the model and supported a higher 2026 drug‑discovery outlook.

Product Line Growth: The introduction of Bunsen, an agentic AI co‑scientist, expands the software portfolio and is being deployed at scale within BMS. This product push complements growth in ACV and broader platform adoption.

Strong Market Position & Advantage: Analyst recognitions place New Relic in the Leaders tier for observability and AIOps, and the company reports holding the No. 1 vendor share in Japan’s APM/observability market. These signals point to durable competitive standing across core categories and select geographies.

Innovation-Driven Growth: Ongoing platform and AI releases through 2025–2026 (e.g., Core Observability enhancements and new AI capabilities such as Autopilot and Ground Truth) indicate sustained product velocity. This cadence suggests active investment aimed at expanding platform adoption and wallet share.

Strategic Partnerships: Milestones and momentum through cloud marketplaces (AWS and Azure) and integrations with ecosystems like ServiceNow highlight meaningful channel reach. These partnerships serve as scalable routes to market that can complement direct sales and consumption growth.

Market Expansion: The merger with Accolite in 2024, global rebrand in 2025, and the 2026 Cartesian acquisition broadened footprint across North America, Europe, and India. Leadership appointments to run the India practice indicate continued investment in global delivery capacity.

Innovation-Driven Growth: The Cartesian deal was positioned to accelerate enterprise AI capabilities, and joining Anthropic’s Claude Partner Network signals an AI-led services push. Feedback suggests these moves deepen data and analytics strengths rather than retrenchment.

Strategic Partnerships: Recent partner accolades such as Acquia’s 2024 North America Partner of the Year and broader ecosystem momentum point to healthy demand and platform depth. Alliances highlighted across AI and digital experience stacks support go-to-market expansion.

Resilient & Sustainable Growth: Parent-company commentary indicates Vertafore delivered steady mid‑single‑digit revenue growth with continued ARR expansion into 2026, supported by solid organic growth in Roper’s Application Software segment. This points to durable, recurring-revenue momentum in a mature P&C insurance software franchise.

Innovation-Driven Growth: Recent launches in 2026—including the Velocity AI platform, multiple AI agents, and ReferenceConnect AI—demonstrate active product investment aimed at driving adoption and upsell across agencies, MGAs, and carriers. The cadence suggests an innovation roadmap aligned to increasing customer value and usage.

Product Line Growth: The November 4, 2024 acquisition of Surefyre was integrated into Vertafore, broadening submission and underwriting capabilities for MGAs and carriers. This tuck‑in expands Vertafore’s addressable workflows and cross‑sell potential.

Profitability: GAAP profitability and expanding Adjusted EBITDA are evident, with FY2026 delivering over $100M in Adjusted EBITDA and profitability continuing in Q1 FY2027. Margin gains reflect efficiency actions and operating leverage noted in recent periods.

Healthy Cash Flow: Cash generation is solid, with FY2026 producing $53.3M in free cash flow and Q1 FY2027 adding roughly $37M. Consistent positive cash flow supports ongoing operations and strategic initiatives.

Investor Backing & Capital Strength: The company completed a $140M Dutch‑auction tender repurchasing 24.3M shares and increased its open‑market repurchase authorization by $100M. These actions signal confidence and capacity to return capital.

Strong Revenue Growth: Subscription revenue reached $3.877B in Q2 2026, growing strongly year over year, with total revenue also advancing. The company raised its full-year 2026 subscription outlook to $15.76–$15.78B and guided continued double-digit growth into Q3.

Product Line Growth: “ServiceNow AI” surpassed $1B in ACV in Q2 2026, acting as a catalyst for deal activity and upsell. Newer AI capabilities layered onto core workflows are described as adding incremental momentum.

Resilient & Sustainable Growth: Current and total RPO climbed to $13.20B and $29.0B, respectively, indicating strong contracted demand ahead. The number of customers above $5M in ACV increased meaningfully, supporting durable multi‑year expansion.

Strong Revenue Growth: Net revenue has increased over consecutive fiscal years to $638.4 million in FY26, building on gains reported in FY24 and FY25. This points to continued top-line expansion.

Investor Backing & Capital Strength: A significant minority investment from New Mountain Capital was announced on August 1, 2025 to accelerate growth, technology and acquisitions under an alternative practice structure. This provides funding capacity to scale and pursue M&A.

Innovation-Driven Growth: The mix is shifting toward advisory and technology services (nearly half of revenue per the firm), with capability additions reinforcing this pivot. The CompliancePoint transaction further broadens cybersecurity, privacy and compliance offerings.

Strong Revenue Growth: Consolidated revenues increased from $253 billion in 2024 to $270.6 billion in 2025, with quarterly gains such as Q4 2025 up 8% year over year. Growth was led primarily by Optum Rx and supported by steady contributions from Optum Insight.

Market Expansion: Expansion through acquisitions such as Holston Medical Group (August 2025) and Alegeus (July 2026), alongside earlier combinations like Change Healthcare and Atrius Health, broadened capabilities across care, pharmacy, and payments. These moves extend Optum’s platform into adjacent services and operating domains.

Diversified Revenue Streams: A multi-segment model—Rx, Insight, and Health—helps sustain aggregate growth even as individual lines vary, with pharmacy and technology businesses offsetting care-delivery softness. Parent-company commentary continuing to frame Optum as a growth engine and raising 2026 guidance underscores the benefit of this portfolio effect.

Strong Market Position & Advantage: Fanatics is described as the category leader in licensed sports merchandise, operating official e‑commerce and in‑venue retail for major leagues and teams and being selected for major events retail like the 2026 FIFA World Cup. Through Fanatics Collectibles/Topps, long‑term and exclusive league licenses (e.g., MLB/MLBPA, NFL/NFLPA, NBA/NBPA, Premier League) reinforce a dominant collectibles position.

Strong Revenue Growth: Independent analyses indicate revenue of roughly $8.1 billion in 2024, reflecting mid‑teens year‑over‑year growth and continuing a multiyear climb. Commentary points to further gains into 2025–2026 alongside scaling newer lines.

Diversified Revenue Streams: The company spans commerce, collectibles, and sports betting, with newer initiatives like global events retail and Fanatics Studios broadening the base. Expansion beyond core apparel helps reduce reliance on a single line while adding incremental growth levers.